Lanean...
Population pharmacokinetics of tofacitinib in patients with psoriatic arthritis
Objective: Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This analysis characterized the pharmacokinetics (PK) of tofacitinib in adult patients with active PsA and evaluated the impact of covariates (baseline characteristics) on the disposition of tofa...
Gorde:
| Argitaratua izan da: | Int J Clin Pharmacol Ther |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Dustri-Verlag Dr. Karl Feistle
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704728/ https://ncbi.nlm.nih.gov/pubmed/31319908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP203516 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|